Neomycin/ Dexameythasone/Xylometazoline
PreclinicalSmall molecule
Neomycin/ Dexameythasone/Xylometazoline is one of 46 small molecule programs targeting Sinusitis. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
45
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
50 competitors in Sinusitis
#DrugCompanyPhaseTrials
1Ketek
SanofiApproved
Avelox
BayerApproved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Kalydeco
Vertex PharmaceuticalsApproved
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Cipro
BayerApproved
Nurtec
PfizerApproved
Omnicef
AbbVieApproved
Pulmicort
SSalix
Approved
Levaquin
WWim Janssens
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- HHuro Biotech Joint Stock Company